Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active...
Reexamination Certificate
2006-04-28
2009-10-27
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
C424S078180, C424S078310
Reexamination Certificate
active
07608253
ABSTRACT:
Poly(ethylene glycol) carbamate derivatives useful as water-soluble pro-drugs are disclosed. These degradable poly(ethylene glycol) carbamate derivatives also have potential applications in controlled hydrolytic degradation of hydrogels. In such degradable hydrogels, drugs may be either trapped in the gel and released by diffusion as the gel degrades, or they may be covalently bound through hydrolyzable carbamate linkages. Hydrolysis of these carbamate linkages releases the amine drug at a controllable rate as the gel degrades.
REFERENCES:
patent: 4760057 (1988-07-01), Alexander
patent: 4935465 (1990-06-01), Garman
patent: 5413992 (1995-05-01), Nicolaou et al.
patent: 5561119 (1996-10-01), Jacquesy et al.
patent: 6011042 (2000-01-01), Greenwald et al.
patent: 0 595 133 (1993-10-01), None
patent: 90/13540 (1990-11-01), None
patent: 96/23794 (1996-08-01), None
patent: 99/30727 (1999-06-01), None
Bentley, et al., “PEG-linked Artemisinin Antimalarials”, Polymer Preprints, 38(1):584-585, (1997).
Greenwald, et al., “Drug delivery systems: anticancer prodrugs and their polymeric conjugates”, Exp. Opin. Ther. Patents, 7(6):601-609, (1997).
Greenwald, et al., “Drug Delivery Systems Employing 1,4-or 1,6-Elimination: Poly(ethylene glycol) Prodrugs of Amine-Containing Compounds”, J. Med. Chem., 42(18):3657-3667, (1999).
Greenwald, et al., “Drug Delivery Systems Based on Trimethyl Lock Lactonization: Poly(ethylene glycol) Prodrugs of Amino-Containing Compounds”, J. Med. Chem., 43(3):475-487, (2000).
Greenwald, et al., “Poly(ethylene glycol) Conjugated Drugs and Prodrugs: A Comprhensive Review”, Critical Review in Therapeutic Drug Carrier Systems, 17(2):101-161, (2000).
Larwood, et al., “Synthesis, Characterization, and in vivo Disposition of Iodinatable Polyethylene Glycol Derivatives: Differences in vivo as a Function of Chain Length”, J. Labelled Compd. Radiopharm.
Ouchi, et al., “Design to Antitumor Agent-Terminated Poly(Ethylene Glycol) Conjugate as Macromolecular Prodrug”, Polymer Preprints, 38(1):582-583, (1997).
Zalipsky, et al., “Attachment of Drugs to Polyethylene Glycols”, Eur. Polym. J., 19(12):1177-1183, (1983).
Zalipsky, et al., “Chemistry of polyethylene glycol conjugates with biologically active molecules”, Advanced Drug Delivery Reviews, 16:157-182, (1995).
Shearwater Polymers, Inc., pp. 2-42 and p. 49, (1995) Catalog.
Shearwater Polymers, Inc., “Polyethylene Glycol Derivatives”, pp. 2-53, (1997-1998) Catalog.
Bentley Michael D.
Zhao Xuan
Nektar Therapeutics
Peselev Elli
Wilson Mark A.
LandOfFree
Hydrolytically degradable carbamate derivatives of poly... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrolytically degradable carbamate derivatives of poly..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrolytically degradable carbamate derivatives of poly... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4073567